Oramed Pharmaceuticals Inc. (ORMP)

NASDAQ: ORMP · Real-Time Price · USD

3.415

-0.015 (-0.44%)

At close: Feb 27, 2026, 4:00 PM EST

3.410

-0.005 (-0.15%)

After-hours: Feb 27, 2026, 6:53 PM EST

Oramed Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Aug '21 Aug 31, 2021
Market Capitalization	136	98	93	471	544	640
Market Cap Growth	36.47%	4.69%	-80.20%	-13.48%	-15.00%	479.35%
Enterprise Value	2	-46	-9	311	444	565
Last Close Price	3.42	2.26	2.15	11.21	13.31	18.35
PE Ratio	3.33	-	16.87	-	-	-
PS Ratio	67.96	-	69.54	174.08	200.54	236.73
PB Ratio	0.69	0.67	0.57	3.11	3.26	5.49
P/TBV Ratio	0.67	0.67	0.57	3.10	3.27	5.53
EV/Sales Ratio	1.05	-	-	115.15	163.83	208.87
Debt / Equity Ratio	0.00	0.00	0.32	0.01	0.00	0.01
Net Debt / Equity Ratio	-0.66	-0.97	-0.69	-1.02	-0.90	-0.86
Net Debt / EBITDA Ratio	10.38	11.25	7.21	3.82	4.05	4.15
Net Debt / FCF Ratio	12.62	16.79	10.64	5.45	4.48	4.65
Asset Turnover	0.01	-	0.01	0.02	-	0.03
Quick Ratio	22.08	24.97	3.05	27.10	19.85	14.10
Current Ratio	22.25	25.19	3.06	27.34	20.08	14.27
Return on Equity (ROE)	24.48%	-12.39%	3.24%	-23.77%	-	-30.78%
Return on Assets (ROA)	-4.22%	-4.25%	-5.16%	-14.95%	-	-17.54%
Return on Capital Employed (ROCE)	-6.10%	-8.50%	-9.40%	-26.00%	-21.70%	-20.00%
Earnings Yield	32.26%	-19.54%	5.93%	-7.77%	-6.44%	-3.48%
FCF Yield	-7.80%	-8.64%	-11.32%	-6.04%	-6.14%	-3.37%
Buyback Yield / Dilution	-3.29%	-0.65%	-4.02%	-5.08%	-30.36%	-16.71%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q